Trial · NCT03152591
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Average Morning Fasting Free Testosterone Blood Concentrations From Baseline | LIK066 | 0.91 | 90% Confidence Interval 0.77 to 1.07 | nmol/L | |
| Change in Average Morning Fasting Free Testosterone Blood Concentrations From Baseline | Placebo | 1.03 | 90% Confidence Interval 0.88 to 1.21 | nmol/L | |
| Change From Baseline in Luteinizing Hormone (LH) at Day 15 | LIK066 | 1.37 | 90% Confidence Interval 1.11 to 1.69 | U/L | |
| Change From Baseline in Luteinizing Hormone (LH) at Day 15 | Placebo | 1.10 | 90% Confidence Interval 0.89 to 1.36 | U/L | |
| Change From Baseline in Follicle Stimulating Hormone (FSH) at Day 15 | LIK066 | 1.13 | 90% Confidence Interval 0.89 to 1.43 | U/L | |
| Change From Baseline in Follicle Stimulating Hormone (FSH) at Day 15 | Placebo | 0.89 | 90% Confidence Interval 0.70 to 1.13 | U/L | |
| Change From Baseline in Sex Hormone Binding Globulin (SHBG) at Day 15 | LIK066 | 1.06 | 90% Confidence Interval 0.95 to 1.20 | nmol/L | |
| Change From Baseline in Sex Hormone Binding Globulin (SHBG) at Day 15 | Placebo | 0.93 | 90% Confidence Interval 0.83 to 1.03 | nmol/L | |
| Change From Baseline in Androstenedione at Day 15 | LIK066 | 0.85 | 90% Confidence Interval 0.74 to 0.97 | nmol/L | |
| Change From Baseline in Androstenedione at Day 15 | Placebo | 1.03 | 90% Confidence Interval 0.91 to 1.17 | nmol/L | |
| Change From Baseline in Dehydroepiandrostenedione (DHEA) at Day 15 | LIK066 | 0.75 | 90% Confidence Interval 0.58 to 0.98 | nmol/L | |
| Change From Baseline in Dehydroepiandrostenedione (DHEA) at Day 15 | Placebo | 1.09 | 90% Confidence Interval 0.85 to 1.39 | nmol/L | |
| Change From Baseline in Dehydroepiandrostenedione Sulfate (DHEAS) at Day 15 | LIK066 | 0.84 | 90% Confidence Interval 0.75 to 0.94 | umol/L | |
| Change From Baseline in Dehydroepiandrostenedione Sulfate (DHEAS) at Day 15 | Placebo | 1.10 | 90% Confidence Interval 0.99 to 1.23 | umol/L | |
| Change From Baseline in Total Testosterone, at Day 15 | LIK066 | 0.95 | 90% Confidence Interval 0.84 to 1.06 | nmol/L | |
| Change From Baseline in Total Testosterone, at Day 15 | Placebo | 1.04 | 90% Confidence Interval 0.92 to 1.17 | nmol/L | |
| Change From Baseline in Free Androgen Index (FAI), at Day 15 | LIK066 | 0.85 | 90% Confidence Interval 0.69 to 1.05 | Ratio | |
| Change From Baseline in Free Androgen Index (FAI), at Day 15 | Placebo | 1.07 | 90% Confidence Interval 0.88 to 1.31 | Ratio |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03152591/results